Login / Signup

Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials?

Keith GomezMichael A LaffanCharlotte Ann Bradbury
Published in: British journal of haematology (2020)
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • phase iii
  • randomized controlled trial
  • double blind